For the roughly 332 million people around the world living with depression, a groundbreaking new clinical trial published in a leading medical journal is offering a genuine and powerful reason for hope. Researchers at Imperial College London studied a naturally occurring compound called DMT, the active ingredient in the traditional Amazonian brew ayahuasca, and found that a single intravenous dose produced significant and lasting reductions in depression symptoms, with effects lasting up to six months in some of the patients who took part. The 34 participants in the trial all had moderate to severe depression and had already tried and failed at least two previous treatments, whether medication or therapy, making them among the most difficult and discouraged cases in the entire field. Most remarkably, the entire therapeutic session lasts only 20 to 30 minutes, compared to the six or more hours required for similar treatments using other psychedelic compounds, which could make it far more practical, accessible, and affordable if it eventually reaches everyday patients around the world.
The compound works, researchers believe, by temporarily encouraging the brain to form new connections and break free from the rigid, repetitive thought patterns that keep people locked in depression, a process scientists call neuroplasticity. Unlike traditional antidepressants that can take weeks to show any meaningful effect, patients in this trial noticed significant changes within just hours and days of a single session. The trial was small, and researchers are careful to note that much larger studies are still needed before DMT could become a standard treatment option available to patients everywhere. But for people who have spent years cycling through medications that never quite worked, the finding that real and lasting relief might come from a single 30-minute session represents something many had stopped believing was still possible: a genuinely new and hopeful door finally swinging open.
Source: https://www.theguardian.com/science/2026/feb/25/ayahuasca-component-dmt-psychedelic
